FDA Regulation: 10 Elements of a New Drug Application for FMT

Though the FDA has repealed its decision to require a new drug application for fecal microbiota transplantation, increased interest in studying FMT for other clinical indications could lead to renewed regulation efforts.

Advertisement

In recent study published in the journal Clinical Gastroenterology and Hepatology, researchers outline the elements of an investigational new drug application for FMT.

•    Product name/chemical structure
•    Proposed indications
•    Dosage and route of administration
•    Background
•    Chemistry, manufacturing and controls information
•    Clinical data summary
•    FMT treatment protocol
•    Adverse event report
•    Risks associated with FMT
•    Safety monitoring protocol

Submission of a new drug application for FMT would also require additional forms, local institutional review board approval and case report forms.

More Articles on Gastroenterology:
10 Recent GI/Endoscopy Physician Moves
14 Statistics on Gastroenterologist Home & Work Satisfaction
AGA: Coordinated Care Between Gastroenterologists & Primary Care Physicians

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.